IFS
VRTX icon

Ifrah Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Ifrah Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.58M Sell
3,022
-34
-1% -$17.4K 0.4% 53
2026
Q2 		$1.52M Sell
3,056
-221
-7% -$97.9K 0.37% 55
2026
Q1 		$1.46M Sell
3,277
-120
-4% -$56K 0.39% 51
2025
Q4 		$1.54M Sell
3,397
-79
-2% -$34.1K 0.4% 50
2025
Q3 		$1.36M Sell
3,476
-25
-0.7% -$10.4K 0.35% 54
2025
Q2 		$1.56M Sell
3,501
-44
-1% -$20.3K 0.43% 48
2025
Q1 		$1.72M Sell
3,545
-273
-7% -$127K 0.49% 45
2024
Q4 		$1.54M Sell
3,818
-132
-3% -$61.2K 0.42% 48
2024
Q3 		$1.84M Sell
3,950
-102
-3% -$49K 0.5% 46
2024
Q2 		$1.9M Sell
4,052
-403
-9% -$175K 0.54% 44
2024
Q1 		$1.86M Sell
4,455
-102
-2% -$43.1K 0.52% 44
2023
Q4 		$1.85M Sell
4,557
-179
-4% -$66.1K 0.54% 41
2023
Q3 		$1.65M Sell
4,736
-49
-1% -$17.1K 0.51% 46
2023
Q2 		$1.68M Sell
4,785
-76
-2% -$25.6K 0.51% 45
2023
Q1 		$1.53M Sell
4,861
-119
-2% -$35.7K 0.49% 48
2022
Q4 		$1.44M Sell
4,980
-165
-3% -$50.3K 0.47% 48
2022
Q3 		$1.49M Sell
5,145
-38
-0.7% -$10.9K 0.51% 49
2022
Q2 		$1.46M Sell
5,183
-82
-2% -$21.9K 0.47% 50
2022
Q1 		$1.37M Buy
5,265
+2,651
+101% +$629K 0.39% 52
2021
Q4 		$574K Buy
+2,614
New +$508K 0.15% 113

Other funds holding VRTX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $5.23B AUM 33.79% 1-Year Est. Return

Ifrah Financial Services's VRTX Position: Q3 2026 in Review

Ifrah Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q3 2026, selling an estimated $17.4K and leaving 3,022 shares worth $1.58M. The position accounts for 0.4% of the portfolio, ranked #53.

Ifrah Financial Services first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.9M in Q2 2024. 124 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Ifrah Financial Services held 3,022 shares of Vertex Pharmaceuticals worth $1.58M as of Q3 2026.
  • Ifrah Financial Services sold 34 Vertex Pharmaceuticals shares in Q3 2026, an estimated $17.4K.
  • Vertex Pharmaceuticals made up 0.4% of Ifrah Financial Services's portfolio in Q3 2026, its #53 holding.
  • Ifrah Financial Services first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • Ifrah Financial Services's Vertex Pharmaceuticals position peaked at $1.9M in Q2 2024.
  • 124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Ifrah Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.